10-Amino-1MQ
Also: NNMT inhibitor (long-form)
Less-studied cousin of 5-Amino-1MQ, marketed for body-composition support.
Evidence
anecdotal
Legal status
research only
Half-life
Estimated several hours
Routes
oral
What it is
10-Amino-1MQ targets the same NNMT pathway as 5-Amino-1MQ, with reported anecdotal preference for fat-loss focused protocols. Pre-clinical literature is sparse compared to the 5-position analog, and no human trials have been published.
Mechanism
Higher-mass analog of 5-Amino-1MQ — inhibits nicotinamide N-methyltransferase (NNMT), preserving NAD+ and SAM availability in adipocytes.
Outcomes it's matched to
- STRENGTH65%
- STRENGTH55%
Safety
Human safety profile unknown. Use only in research contexts.
- Pregnancy
- Active liver disease
Legal context
Research chemical. No human approval.